The Gray Market Drug Reform and Transparency Act (H.R. 5853) was introduced in the 112th Congress, which has adjourned.

It has not yet been reintroduced.

You can increase the chances that the bill is revived in the new Congress by showing support for reintroduction.

Want to be notified when this bill is reintroduced?

View H.R. 5853 (112th) report

What’s your position on
The Gray Market Drug Reform and Transparency Act

H.R. 5853: Gray Market Drug Reform and Transparency Act of 2012

Summary: To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce. (More Info)

The Gray Market Drug Reform and Transparency Act (H.R. 5853) was introduced in the 112th Congress, which has adjourned. It has not yet been reintroduced.

What POPVOX Users Say

POPVOX Nation:
50% Support
50% Oppose
(2 users)

View Report & Comments

1 users
1 users
order determined by social media popularity

Endorsing Organizations

No organization has endorsed this bill yet on POPVOX.